Springer Nature is making SARS-CoV-2 and COVID-19 research free View research | View latest news | Sign up for updates

Possible use of [125I]-labeled helix agglutinins for early diagnosis of tumor and metastatic growth

  • 15 Accesses

This is a preview of subscription content, log in to check access.

Literatur

  1. [1]

    Prokop, O., et al.: Dtsch. Gesundh.-Wes.23, 1926 (1968).

  2. [2]

    Ardenne, M. von, et al.: ibid.24, 588 (1969).

  3. [3]

    Prokop, O., Graffi, A., Schnitzler, St.: Acta biol. med. germ.20, K9 (1968).

  4. [3a]

    Schnitzler, St., Prokop, O.: Z. Immun.-Forsch.138, 41 (1969).

  5. [4]

    Voss, H., et al.: Zbl. Bakt.203, 249 (1967).

  6. [5]

    Sylvén, B., Bois, I.: Cancer Res.20, 831 (1960).

  7. [6]

    Davidsohn, I., Ni, L. Y.: Am. J. Pathol.57, 307 (1969).

  8. [7]

    Ceska, M., Sjödin, A. V., Grossmüller, F.: Biochem. J.121, 139 (1971).

  9. [8]

    Ardenne, M. von, et al.: Dtsch. Gesundh.-Wes.25, 817 (1970).

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

von Ardenne, M., Chaplain, R.A. Possible use of [125I]-labeled helix agglutinins for early diagnosis of tumor and metastatic growth. Naturwissenschaften 59, 278 (1972). https://doi.org/10.1007/BF00610217

Download citation

Keywords

  • Early Diagnosis
  • Metastatic Growth